Shares of MJ Gleeson plc (LON:GLE – Get Free Report) traded down 0.8% on Thursday . The stock traded as low as GBX 515 ($6.50) and last traded at GBX 520 ($6.56). 62,326 shares changed hands during trading, a decline of 13% from the average session volume of 71,376 shares. The stock had previously closed at GBX 524 ($6.61).
Wall Street Analyst Weigh In
Separately, Berenberg Bank restated a “buy” rating and set a GBX 643 ($8.12) price target on shares of MJ Gleeson in a research report on Wednesday, September 18th.
Check Out Our Latest Research Report on GLE
MJ Gleeson Price Performance
MJ Gleeson Increases Dividend
The company also recently disclosed a dividend, which was paid on Friday, November 22nd. Stockholders of record on Thursday, October 24th were issued a GBX 7 ($0.09) dividend. This represents a dividend yield of 1.25%. This is a positive change from MJ Gleeson’s previous dividend of $4.00. The ex-dividend date of this dividend was Thursday, October 24th. MJ Gleeson’s dividend payout ratio (DPR) is presently 3,333.33%.
Insider Buying and Selling
In related news, insider Stefan Allanson sold 10,532 shares of the business’s stock in a transaction on Thursday, October 17th. The shares were sold at an average price of GBX 620 ($7.83), for a total value of £65,298.40 ($82,416.26). Also, insider Christopher H. B. Mills sold 300,000 shares of the company’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of GBX 610 ($7.70), for a total value of £1,830,000 ($2,309,731.16). Insiders own 16.85% of the company’s stock.
About MJ Gleeson
MJ Gleeson plc engages in low-cost house building and land promotion activities in the United Kingdom. The company operates through two divisions, Gleeson Homes and Gleeson Land. It also engages in the house building activities in the north of England and Midlands; and sale of land in the south of England.
Further Reading
- Five stocks we like better than MJ Gleeson
- How to Invest in Biotech Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The Basics of Support and Resistance
- Texas Instruments: The Old-School Tech Titan Still Delivering
- P/E Ratio Calculation: How to Assess Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for MJ Gleeson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MJ Gleeson and related companies with MarketBeat.com's FREE daily email newsletter.